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Abstract
Bruck syndrome is an autosomal recessive syndrome consisting of bone fragility and congenital joint contractures. According to the 
genotype, it has been classified into types 1 and 2. Recently, mutations in FKBP10, localised to chromosome 17q21, have been identified 
in some patients of Bruck syndrome. Twenty-seven patients of this syndrome have been reported so far. We present a new patient of this 
syndrome, with frequent fractures, congenital joint contractures, kyphoscoliosis, bilateral clubfoot, and pectus carinatum. The clinical and 
genetic features of all previously reported cases are also reviewed. (Endokrynol Pol 2015; 66 (2): 170–174)
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Streszczenie
Zespół Brucka jest autosomalną chorobą recesywną, na którą składa się kruchość kości i wrodzone przykurcze stawowe. Zgodnie z ge-
notypem zespół ten można podzielić na typ 1 i 2. Ostatnio, u niektórych pacjentów z zespołem Brucka wykryto mutacje FKBP10, genu 
zlokalizowanego na chromosomie 17q21. Do tej pory zarejestrowano 27 pacjentów z tym zespołem. Autorzy przedstawiają nowego 
pacjenta ze zdiagnozowanym zespołem Brucka, z częstymi złamaniami, wrodzonymi przykurczami stawowymi, kifoskoliozą kręgosłupa, 
obustronną stopą końsko-szpotawą i klatką piersiową kurzą. Przytoczymy również kliniczne i genetyczne cechy wszystkich wcześniej 
potwierdzonych przypadków. (Endokrynol Pol 2015; 66 (2): 170–174)
Słowa kluczowe: Bruck; przykurcz stawu; wrodzona łamliwość kości; Artrogrypoza; nowa mutacja genu FKBP10
Introduction
Bruck syndrome (BS) is a very rare syndrome in which 
bone fragility is associated with congenital joint contrac-
tures. It has been considered as an autosomal recessive 
form of osteogenesis imperfecta (OI) [1]. 
In 1989 Viljoen et al. reported five children with 
frequent fractures and arthrogryposis multiplex [2]. Be-
cause the same disorder had been reported by Dr. Bruck 
in 1897 [3], Viljoen et al. suggested that the disorder be 
called Bruck syndrome. To the best of our knowledge, 
27 cases of BS have been reported in the literature so 
far. The first mutations discovered in BS patients were 
PLOD2 mutations, but evidence for the role of chromo-
some 17 in Bruck syndrome has lead to identifying the 
FKBP10 gene as a responsible locus [4–6]. 
The FKBP10 gene has been located on chromosome 
17q21.2 and contain 10538 base pairs and transcript to 
a 2888bp mRNA with 11 exons, which encodes a protein 
with 582 amino acids that belongs to the  FKBP-type 
peptidyl-prolyl cis/trans isomerase (PPIase) family. 
FKBP10 contains four sequential peptidyl-prolyl cis-
trans isomerase (PPIase FKBP-type) domains at N 
terminal and 2 EF-hand domains (calcium-binding 
domain) at C terminal. This protein is known as a mo-
lecular chaperone and is located in the endoplasmic 
reticulum [7]. The ability of FK506 Binding Protein 10 
(FKBP10) to act as a collagen chaperone justifies its role 
in the pathogenesis of osteogenesis imperfecta [4, 8]. 
Recently, mutations in FKBP10 have been detected in 
a few BS patients. FKBP10 mutation is associated with 
phenotype heterogeneity [9].
In the present article, a case of BS with novel muta-
tion in FKBP10 is reported from Shiraz, Iran. A brief 
review of clinical and genetic characteristics of all previ-
ously reported cases of BS will be discussed. 
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Report of the case
The patient was a four-year-old girl, the second child 
of a first cousin consanguineous marriage from healthy 
Iranian parents. She was the product of a normal preg-
nancy born by caesarean section due to abnormal foetal 
presentation. She had good Apgar scores at birth and 
a birth weight of 2700 grams. Another child of the fam-
ily is a normal boy.
Immediately after birth, contracture of both knees 
and elbows were detected. 
The first fracture was at eight months of age, and 
second fracture was at two years of age, but during the 
third year of her life, she had four episodes of fracture 
in the extremities and ribs. 
In physical exam, she had short stature (height at 
4 years of age was about 94 cm, between 3rd and 10th 
percentiles), white sclera, normal teeth, normal hearing, 
no dysmorphic facial features, mild pectus carinatum, 
kyphoscoliosis, bilateral contractures and pterygia of 
knees and elbows, mild bilateral clubfoot, and over-
riding of second and third digits of the right foot. Her 
cognitive function was normal (Fig. 1).
Radiographic evaluation showed signs of old frac-
tures in both lower and left upper extremities. Skull 
X-ray was normal without visible wormian bones. 
There was no positive family history for congenital joint 
contracture or frequent fractures.
Since she was three years old, intravenous pa-
midronate (1 mg/kg/day, for 3 consecutive days) was 
started every three months, and frequent castings were 
applied to decrease joint contractures.
After one year of treatment, she had only one frac-
ture, with slight improvement of joint contractures. 
Genetic study with the impression of B.S. was per-
formed for the patient and her parents with informed 
consent at the Collagen Diagnostic Laboratory, University 
of Washington. No mutation was identified in the PLOD2 
gene. Sequencing the FKBP10 gene revealed a homozy-
gous mutation in the FKBP10 gene, which consisted of 
Figure 1. Photograph of the patient, flexion contracture of different joints is noted
Rycina 1. Fotografia pacjenta, widoczny jest przykurcz zgięciowy różnych stawów
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Figure 2. Photograph of the patient
Rycina 2. Fotografia pacjenta
a deletion of a single cytosine nucleotide (del C) and 
an insertion of three adenine nucleotides in exon 1 (ins 
AAA) c.204delCinsAAA and/or p.His68Glnfs*92, which 
corresponds to a net gain of two nucleotides. This leads 
to a reading frame shift and the creation of a premature 
termination codon downstream in exon 3. This mutation 
has not been detected previously, and this is the first case 
with this mutation. Informed written consent was taken 
from the parents before submission of this report.
Discussion
Bruck syndrome was first reported by Dr. Bruck in 1897 
[3]. Viljoen et al. in 1989 reported five children with 
multiple fractures and congenital joint contractures, 
and they suggested that this disorder be named Bruck 
syndrome [2]. FKBP10 mutation causes phenotype 
heterogeneity. It is a cause of osteogenesis imperfecta 
with different severities and also a cause of B.S. [8].
The first PPIase domain in FKBP10 protein contains 
89 amino acids (from codon 62 to codon 150). Exon 1 
of FKBP10 gene has 349 bp lengths and encodes 81 
amino acids, this region is a conserved sequence and 
codes part of the first FKBP-type peptidyl-prolyl cis-
trans isomerase domain. Insertion of AAA instead of 
C in position 204 of cDNA and codon 68 of protein 
sequence substitutes histidine with glutamine residue, 
but translation with reading frame shift continues to 
codon 158 in exon 3 and then termination codon due 
to this mutation makes a premature peptide chain [7]. 
So this mutation is located around the beginning 
of the first PPIase FKBP-type conserved domain, and 
it seems to lead to a radical transformation in peptide 
structure and folding and results in loss of function of 
FKBP65 protein, which in turn has several effects: secre-
tion of type 1 procollagen is delayed, the stabilisation of 
the intact trimer becomes incomplete, and hydroxyla-
tion of the telopeptide lysyl residue, which is involved 
in intermolecular cross-link formation in bone, is de-
creased. The clinical effects of these molecular changes 
are short stature, high incidence of joint contractures, 
frequent fractures, and scoliosis [5, 6] 
BS has been classified into types 1 and 2 [9]. BS type 
2 has been linked to mutations in PLOD2 [10, 11]. The 
aetiology of type 1 BS has not been determined, but 
it has been linked to chromosome 17, possibly region 
17 P12 [12]. Recently, mutations in FKBP10, localised 
to chromosome 17q21, have been identified in some 
cases of BS [9]. These mutations are also associated 
with some cases of autosomal recessive osteogenesis 
imperfecta without arthrogryposis. Therefore, FKBP10 
mutations have diverse phenotypic features, including 
osteogenesis imperfecta with or without congenital 
joint contractures [6, 11]. BS is defined as congenital 
joint contractures associated with multiple fractures; 
therefore, our patient has clinical criteria of BS, but she 
has no specific clinical finding that can be attributed to 
the novel mutation in FKBP10. Researchers that have 
reported BS patients with mutations in FKBP10 have 
not found any specific clinical difference between these 
patients and other BS patients. Schwarze et al. identi-
fied 38 cases of osteogenesis imperfecta with FKBP10 
mutations. They also found that there is remarkable 
variability in phenotype even within families [4, 5, 9].
So far, to the best of our knowledge, at least 27 cases 
of BS have been reported. Clinical features of BS are the 
same in different genotypes [10]. In addition to multi-
ple bone fractures and congenital joint contractures, 
patients commonly have short stature, skull wormian 
bones, and kyphoscoliosis. 
Most but not all of the cases had normal teeth, white 
sclera, normal cognitive functions, and normal hearing. 
A few cases had dysmorphic features including trian-
gular face and brachycephaly [13–19]. Most BS cases 
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treated with pamidronate had good to fair response. 
Therefore, pamidronate therapy with the same doses 
used in OI is recommended for these patients. Impor-
tant clinical and genetic features of all reported cases 
of BS are presented in Table I [20, 21]. 
According to the expanding number of cases of 
Bruck syndrome, it is necessary for physicians to have 
more information about clinical and paraclinical aspects 
of this disorder.
It is recommended that patients with multiple frac-
tures and joint contracture have detailed clinical and 
paraclinical evaluation for detection of this disease. 
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